GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthwell Acquisition Corp I (NAS:HWEL) » Definitions » Total Current Liabilities

Healthwell Acquisition I (Healthwell Acquisition I) Total Current Liabilities : $2.66 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Healthwell Acquisition I Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Healthwell Acquisition I's total current liabilities for the quarter that ended in Jun. 2023 was $2.66

Healthwell Acquisition I Total Current Liabilities Historical Data

The historical data trend for Healthwell Acquisition I's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthwell Acquisition I Total Current Liabilities Chart

Healthwell Acquisition I Annual Data
Trend Dec21 Dec22
Total Current Liabilities
0.28 0.93

Healthwell Acquisition I Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.62 0.93 1.12 2.66

Healthwell Acquisition I Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Healthwell Acquisition I's Total Current Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.928+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.93

Healthwell Acquisition I's Total Current Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=2.387+0.276
+Other Current Liabilities+Current Deferred Liabilities
=0.00099999999999989+0
=2.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Healthwell Acquisition I Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Healthwell Acquisition I's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthwell Acquisition I (Healthwell Acquisition I) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthwell Acquisition Corp I (NAS:HWEL) » Definitions » Total Current Liabilities
Comparable Companies
PWUP BLUA CBRG CHAA NNAG TGAA DPCS EGGF PORT CITE PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
1001 Green Bay Road, Suite 227, Winnetka, IL, USA, 60093
Website
https://www.healthwellspac.com
Healthwell Acquisition Corp I is a blank check company.
Executives
Ellen Levy director C/O INSTRUCTURE, INC., 6330 SOUTH 3000 EAST, SUITE 700, SALT LAKE CITY UT 84121
George R Hornig director 625 MADISON AVE SUITE 10-B, NEW YORK NY 10017
Christie Hefner director PLAYBOY ENT., INC. - H. SHAPIRO, 680 N. LAKE SHORE DRIVE, CHICAGO IL 60611
John L Maccarthy director, 10 percent owner 333 WEST WACKER DRIVE, C/O NUVEEN INVESTMENTS, CHICAGO IL 60606
Healthwell Acquisition Corp. I Sponsor Llc 10 percent owner 1001 GREEN BAY RD. #227, WINNETKA IL 60093
Alyssa Rapp director, 10 percent owner, officer: Chief Executive Officer C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Curtis Feeny director C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Carl Allegretti director C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Tracy Wan director, officer: Chief Financial Officer C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Matt Wandoloski director C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093

Healthwell Acquisition I (Healthwell Acquisition I) Headlines

From GuruFocus

Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate

By Business Wire • 11-18-2023

Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments

By Business Wire Business Wire • 04-27-2023

Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions

By Business Wire • 10-24-2023

Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma

By Business Wire • 09-13-2023

Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference

By Business Wire Business Wire • 06-06-2023

Healthwell Acquisition Corp. I Announces the Separate Trading of Its Class A Common Stock and Warrants Commencing September 23, 2021

By Business Wire Business Wire • 09-22-2021

Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions

By Business Wire • 10-17-2023

Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

By Business Wire • 10-04-2023

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

By Business Wire Business Wire • 06-12-2023

Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.

By Business Wire • 11-04-2023